Intermediate α1-antitrypsin deficiency PiSZ: a risk factor for pulmonary emphysema?
- 28 February 1998
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 92 (2) , 241-245
- https://doi.org/10.1016/s0954-6111(98)90102-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Survival of patients with severe alpha 1-antitrypsin deficiency with special reference to non-index cases.Thorax, 1994
- Risk Factors for Reduced Pulmonary Function in WomenChest, 1992
- Heterozygosity of α1-Antitrypsin: A Health Risk?Critical Reviews in Clinical Laboratory Sciences, 1989
- Molecular basis of alpha-1-antitrypsin deficiencyThe American Journal of Medicine, 1988
- Alpha1-Antitrypsin Pi-Types in 965 COPD PatientsChest, 1986
- Alpha1antitrypsin deficiency: Clinical and physiological features in heterozygotes of Pi types SZ: A survey by the British Thoracic AssociationRespiratory Medicine, 1983
- Alpha1antitrypsin deficiency: The clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type ZRespiratory Medicine, 1983
- Natural History and Life Expectancy in Severe Alpha1‐Antitrypsin Deficiency, Pi ZActa Medica Scandinavica, 1978
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Pulmonary Emphysema and Alpha1‐Antitrypsin DeficiencyActa Medica Scandinavica, 1964